Myra Ann Lipes, M.D.,C.M.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autoimmunity | 6 | 2020 | 1349 | 1.510 |
Why?
|
| Diabetes Mellitus, Type 1 | 15 | 2020 | 3336 | 1.060 |
Why?
|
| Myocardium | 6 | 2019 | 4776 | 0.960 |
Why?
|
| Ventricular Myosins | 2 | 2012 | 50 | 0.830 |
Why?
|
| Chagas Cardiomyopathy | 2 | 2019 | 72 | 0.750 |
Why?
|
| Myosin Heavy Chains | 2 | 2019 | 414 | 0.670 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2020 | 96 | 0.660 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2019 | 130 | 0.650 |
Why?
|
| Islets of Langerhans | 7 | 2005 | 1352 | 0.530 |
Why?
|
| Myocarditis | 4 | 2019 | 771 | 0.530 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2012 | 4386 | 0.460 |
Why?
|
| Heart | 2 | 2020 | 4467 | 0.430 |
Why?
|
| HLA-DQ Antigens | 3 | 2011 | 210 | 0.380 |
Why?
|
| Parvovirus B19, Human | 1 | 2010 | 38 | 0.380 |
Why?
|
| Heart Diseases | 2 | 2015 | 2788 | 0.380 |
Why?
|
| Mice, Inbred NOD | 11 | 2011 | 1878 | 0.360 |
Why?
|
| Hyperglycemia | 1 | 2019 | 1373 | 0.360 |
Why?
|
| Insulin | 9 | 2006 | 6580 | 0.290 |
Why?
|
| T-Lymphocytes | 4 | 2019 | 10180 | 0.250 |
Why?
|
| Pituitary Gland | 3 | 2001 | 665 | 0.220 |
Why?
|
| Autoantigens | 3 | 2019 | 892 | 0.210 |
Why?
|
| Mice, Transgenic | 11 | 2011 | 9734 | 0.210 |
Why?
|
| Glucokinase | 1 | 2001 | 103 | 0.190 |
Why?
|
| Thymus Gland | 3 | 2012 | 1267 | 0.190 |
Why?
|
| Autoantibodies | 3 | 2019 | 2035 | 0.180 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2001 | 440 | 0.170 |
Why?
|
| Autoimmune Diseases | 2 | 2004 | 2133 | 0.160 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2002 | 1821 | 0.120 |
Why?
|
| Brazil | 1 | 2019 | 1270 | 0.120 |
Why?
|
| Myocardial Infarction | 2 | 2012 | 11727 | 0.120 |
Why?
|
| Disease Models, Animal | 4 | 2011 | 18029 | 0.120 |
Why?
|
| HLA Antigens | 1 | 2019 | 1381 | 0.110 |
Why?
|
| Phenotype | 1 | 2010 | 16365 | 0.110 |
Why?
|
| Antigens | 1 | 2019 | 1466 | 0.110 |
Why?
|
| Adoptive Transfer | 3 | 2006 | 844 | 0.110 |
Why?
|
| Mice | 17 | 2012 | 81183 | 0.100 |
Why?
|
| Genetic Engineering | 1 | 1997 | 951 | 0.100 |
Why?
|
| Parvoviridae Infections | 1 | 2010 | 35 | 0.100 |
Why?
|
| Proinsulin | 2 | 2004 | 133 | 0.100 |
Why?
|
| DNA Primers | 2 | 2011 | 2892 | 0.100 |
Why?
|
| Rheumatic Heart Disease | 1 | 2012 | 177 | 0.090 |
Why?
|
| Crosses, Genetic | 3 | 2006 | 791 | 0.090 |
Why?
|
| Cardiac Myosins | 1 | 2011 | 117 | 0.090 |
Why?
|
| Animals | 19 | 2015 | 168757 | 0.090 |
Why?
|
| Hypoglycemic Agents | 1 | 2002 | 2872 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1993 | 805 | 0.080 |
Why?
|
| Glucose | 1 | 2001 | 4397 | 0.080 |
Why?
|
| Base Sequence | 5 | 2011 | 12797 | 0.080 |
Why?
|
| Prevalence | 2 | 2019 | 15226 | 0.080 |
Why?
|
| Genes, MHC Class II | 1 | 1988 | 457 | 0.080 |
Why?
|
| Cloning, Molecular | 2 | 1991 | 4320 | 0.070 |
Why?
|
| Heart Failure | 1 | 2010 | 10900 | 0.070 |
Why?
|
| Risk | 1 | 2019 | 9687 | 0.070 |
Why?
|
| Pro-Opiomelanocortin | 2 | 1997 | 163 | 0.070 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2012 | 851 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 5 | 2011 | 21827 | 0.070 |
Why?
|
| Mice, Knockout | 4 | 2011 | 14557 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 2 | 2002 | 2699 | 0.060 |
Why?
|
| Multiple Sclerosis | 1 | 2019 | 3079 | 0.060 |
Why?
|
| DNA, Viral | 1 | 2010 | 2225 | 0.060 |
Why?
|
| Lymphocyte Transfusion | 1 | 2004 | 236 | 0.050 |
Why?
|
| Chemical Precipitation | 1 | 2002 | 179 | 0.050 |
Why?
|
| Humans | 14 | 2020 | 744343 | 0.050 |
Why?
|
| Immune Tolerance | 1 | 2011 | 2258 | 0.050 |
Why?
|
| Gene Products, tat | 1 | 2002 | 120 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2015 | 35421 | 0.050 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2002 | 156 | 0.050 |
Why?
|
| Viral Load | 1 | 2010 | 3299 | 0.050 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2001 | 62 | 0.050 |
Why?
|
| Blotting, Northern | 2 | 2001 | 1581 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2019 | 21746 | 0.050 |
Why?
|
| Insulin Infusion Systems | 1 | 2002 | 212 | 0.050 |
Why?
|
| Antigen-Presenting Cells | 1 | 2004 | 973 | 0.050 |
Why?
|
| Oxides | 1 | 2002 | 405 | 0.050 |
Why?
|
| Protein Precursors | 1 | 2004 | 1154 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2001 | 643 | 0.050 |
Why?
|
| Female | 8 | 2020 | 380194 | 0.040 |
Why?
|
| Male | 7 | 2020 | 350118 | 0.040 |
Why?
|
| Molecular Sequence Data | 5 | 2004 | 18111 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2005 | 1116 | 0.040 |
Why?
|
| Biopsy | 1 | 2010 | 6756 | 0.040 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 1999 | 171 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 2000 | 563 | 0.040 |
Why?
|
| Spleen | 1 | 2004 | 2362 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2006 | 2540 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2001 | 1099 | 0.040 |
Why?
|
| Apoptosis | 2 | 2005 | 9727 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2001 | 2327 | 0.040 |
Why?
|
| Time Factors | 1 | 2019 | 40075 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2000 | 686 | 0.040 |
Why?
|
| Cardiomegaly | 1 | 1999 | 620 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2002 | 2716 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2001 | 1730 | 0.030 |
Why?
|
| Phosphoproteins | 2 | 1995 | 2440 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 40561 | 0.030 |
Why?
|
| Cell Death | 1 | 2001 | 1706 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2001 | 5179 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2001 | 2025 | 0.030 |
Why?
|
| Disease Progression | 1 | 2010 | 13284 | 0.030 |
Why?
|
| Adult | 3 | 2019 | 214055 | 0.030 |
Why?
|
| Iron | 1 | 2002 | 1774 | 0.030 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1993 | 113 | 0.030 |
Why?
|
| Inflammation | 1 | 2012 | 10638 | 0.030 |
Why?
|
| Young Adult | 1 | 2019 | 56430 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2001 | 8436 | 0.030 |
Why?
|
| Viral Matrix Proteins | 1 | 1993 | 186 | 0.030 |
Why?
|
| Middle Aged | 2 | 2020 | 213383 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2004 | 4560 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2002 | 3760 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 708 | 0.020 |
Why?
|
| Carboxypeptidases | 1 | 1991 | 176 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2005 | 11725 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 23338 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2011 | 25625 | 0.020 |
Why?
|
| Pancreatic Diseases | 1 | 1993 | 350 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 1993 | 390 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 1994 | 2015 | 0.020 |
Why?
|
| Phytohemagglutinins | 1 | 1988 | 170 | 0.020 |
Why?
|
| Infant | 1 | 2011 | 35136 | 0.020 |
Why?
|
| Receptor, Insulin | 1 | 1993 | 846 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 10943 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 1993 | 1035 | 0.020 |
Why?
|
| Contrast Media | 1 | 2002 | 5300 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2004 | 12072 | 0.020 |
Why?
|
| RNA, Antisense | 1 | 1988 | 138 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1996 | 1990 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 1 | 1993 | 1041 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2006 | 5751 | 0.020 |
Why?
|
| Proteins | 2 | 2000 | 6103 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2001 | 19229 | 0.020 |
Why?
|
| Genes, RAG-1 | 1 | 2006 | 68 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 1993 | 6171 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2004 | 17446 | 0.020 |
Why?
|
| Risk Factors | 1 | 2012 | 72290 | 0.020 |
Why?
|
| Annexin A5 | 1 | 2005 | 103 | 0.020 |
Why?
|
| Carbocyanines | 1 | 2005 | 174 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 1995 | 2916 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1993 | 2617 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 1996 | 5867 | 0.020 |
Why?
|
| Cytokines | 1 | 1999 | 7322 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2004 | 13815 | 0.020 |
Why?
|
| Infrared Rays | 1 | 2005 | 249 | 0.010 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 1995 | 563 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2004 | 573 | 0.010 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 1995 | 437 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2010 | 77449 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1988 | 2126 | 0.010 |
Why?
|
| Heterozygote | 1 | 2006 | 2804 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1999 | 330 | 0.010 |
Why?
|
| Receptor, trkA | 1 | 1999 | 164 | 0.010 |
Why?
|
| RNA | 1 | 1988 | 2749 | 0.010 |
Why?
|
| Transfection | 2 | 1999 | 5892 | 0.010 |
Why?
|
| Signal Transduction | 3 | 1999 | 23403 | 0.010 |
Why?
|
| Aged | 1 | 2010 | 163280 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 1999 | 317 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2006 | 3206 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1988 | 5524 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1999 | 575 | 0.010 |
Why?
|
| Glycosylation | 1 | 1999 | 1126 | 0.010 |
Why?
|
| GRB2 Adaptor Protein | 1 | 1995 | 103 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1993 | 9648 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 6386 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 1995 | 2938 | 0.010 |
Why?
|
| DNA | 1 | 1988 | 7301 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2000 | 1338 | 0.010 |
Why?
|
| Aging | 1 | 1993 | 8664 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 1994 | 457 | 0.010 |
Why?
|
| Polysaccharides | 1 | 1999 | 1053 | 0.010 |
Why?
|
| Growth | 1 | 1994 | 376 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2006 | 4479 | 0.010 |
Why?
|
| Carboxypeptidase H | 1 | 1991 | 9 | 0.010 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 1993 | 150 | 0.010 |
Why?
|
| Genes, Viral | 1 | 1993 | 718 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1993 | 898 | 0.010 |
Why?
|
| Burkitt Lymphoma | 1 | 1993 | 327 | 0.010 |
Why?
|
| Tyrosine | 1 | 1994 | 1461 | 0.010 |
Why?
|
| Viral Envelope Proteins | 1 | 1993 | 635 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1990 | 53288 | 0.000 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1995 | 2915 | 0.000 |
Why?
|
| Tumor Cells, Cultured | 1 | 1993 | 6314 | 0.000 |
Why?
|
| Antibodies | 1 | 1991 | 2460 | 0.000 |
Why?
|
| Rats | 1 | 1999 | 24260 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1993 | 3748 | 0.000 |
Why?
|
| Insulin Resistance | 1 | 1994 | 3864 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1994 | 6256 | 0.000 |
Why?
|
| Mutation | 1 | 1993 | 29786 | 0.000 |
Why?
|